Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Consolidated Statements Of Cash Flows [Abstract]
Net income	$ 6,421	$ 2,006
Adjustments to reconcile net income to net cash from (used by) operating activities:
Depreciation	97	86
Amortization, net	(711)	(159)
Deferred income tax (benefit)	(8)	(38)
Originations of loans held for sale	(920,058)	(342,138)
Proceeds from sale of loans held for sale	763,245	377,294
Net gains on sales of loans	(6,360)	(2,844)
Provision for loan and lease losses
Loss on disposal of premises and equipment	3
Earnings on bank owned life insurance	(90)	(36)
Gain on redemption of life insurance policies	(380)
Stock-based compensation expense	161	143
Net change in:
Accrued interest receivable and other assets	5,429	(6,588)
Operating lease right-of-use asset	102	95
Operating lease right-of-use liability	(112)	(104)
Accrued interest payable and other liabilities	(10,141)	7,232
Net cash from (used by) operating activities	(162,402)	34,949
Cash flows from investing activities
Available-for-sale securities: Maturities, prepayments and calls	2,007	2,518
Available-for-sale securities: Purchases	(3,095)	(5,552)
Purchase of bank owned life insurance	(8,000)
Loan and lease originations and payments, net	(54,838)	(42,993)
Additions to premises and equipment	(139)	(135)
Purchase of FRB and FHLB Stock	(317)	(502)
Purchase of other investments	(348)	(1,000)
Return of investment- joint ventures	136
Proceeds from the redemption of life insurance policies	658
Net cash from (used by) investing activities	(63,936)	(47,664)
Cash flows from financing activities:
Net change in deposits	207,310	2,182
Proceeds from FHLB advances and other debt	96,500	122,400
Repayments on FHLB advances and other debt	(116,965)	(82,025)
Net change in warehouse line of credit	(56,067)
Net change in advances by borrowers for taxes and insurance	(108)	(293)
Cash dividends paid on common stock	(196)
Proceeds from exercise of stock options	106
Acquisition of treasury shares surrendered upon vesting of restricted stock for payment of taxes	(22)	(27)
Purchase of treasury shares		(49)
Net cash from financing activities	130,558	42,188
Net change in cash and cash equivalents	(95,780)	29,473
Beginning cash and cash equivalents	221,594	45,879
Ending cash and cash equivalents	125,814	75,352
Supplemental cash flow information:
Interest paid	3,108	3,624
Supplemental noncash disclosures:
Loans transferred from held for sale to portfolio	15,885	1,404
Investment payable on limited partnerships	521
Initial recognition of operating right-of-use lease asset	252
Initial recognition of operating right-of-use lease liability	$ 252
Loans held for sale funded with other debt, net of repayments		$ 13,202